David M. Urso's most recent trade in MEI Pharma Inc was a trade of 166,571 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 2, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MEI Pharma Inc | David M. Urso | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2023 | 166,571 | 166,571 | - | - | Stock Option (Right to Buy) | |
| MEI Pharma Inc | David M. Urso | Chief Operating Officer & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 1,050,000 | 1,050,000 | - | - | Stock Option (Right to Buy) | |
| MEI Pharma Inc | David M. Urso | Chief Operating Officer & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 600,000 | 600,000 | - | - | Stock Option (Right to Buy) | |
| MEI Pharma Inc | David M. Urso | Chief Operating Officer & GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.94 per share. | 01 Jul 2021 | 24,825 | 49,281 (0%) | 0% | 2.9 | 72,986 | Common Stock |